A primary endpoint analysis of the NRG Oncology Phase III clinical trial NRG-GU003 comparing hypofractionated post-operative prostate bed radiotherapy (HYPORT) to the conventional post-prostatectomy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback